Loria F - Search Results

1

Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreich's Ataxia Patients.

Pérez-Luz S, Loria F, Katsu-Jiménez Y, Oberdoerfer D, Yang OL, Lim F, Muñoz-Blanco JL, Díaz-Nido J. Pérez-Luz S, et al. Among authors: loria f. Int J Mol Sci. 2020 Sep 11;21(18):6662. doi: 10.3390/ijms21186662. Int J Mol Sci. 2020. PMID: 32933002 Free PMC article.

2

Frataxin knockdown in human astrocytes triggers cell death and the release of factors that cause neuronal toxicity.

Loría F, Díaz-Nido J. Loría F, et al. Neurobiol Dis. 2015 Apr;76:1-12. doi: 10.1016/j.nbd.2014.12.017. Epub 2014 Dec 29. Neurobiol Dis. 2015. PMID: 25554687 Free article.

3

Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency.

Katsu-Jiménez Y, Loría F, Corona JC, Díaz-Nido J. Katsu-Jiménez Y, et al. Among authors: loria f. Mol Ther. 2016 May;24(5):877-89. doi: 10.1038/mt.2016.32. Epub 2016 Feb 5. Mol Ther. 2016. PMID: 26849417 Free PMC article.

4

The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes.

Vicente-Acosta A, Giménez-Cassina A, Díaz-Nido J, Loria F. Vicente-Acosta A, et al. Among authors: loria f. J Neuroinflammation. 2022 Apr 12;19(1):93. doi: 10.1186/s12974-022-02442-w. J Neuroinflammation. 2022. PMID: 35413853 Free PMC article.

5

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.

Mestre L, Iñigo PM, Mecha M, Correa FG, Hernangómez-Herrero M, Loría F, Docagne F, Borrell J, Guaza C. Mestre L, et al. Among authors: loria f. J Neuroinflammation. 2011 Aug 18;8:102. doi: 10.1186/1742-2094-8-102. J Neuroinflammation. 2011. PMID: 21851608 Free PMC article.

6

Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection.

Vicente-Acosta A, Ceprian M, Sobrino P, Pazos MR, Loría F. Vicente-Acosta A, et al. Among authors: loria f. Front Pharmacol. 2022 Jun 1;13:888222. doi: 10.3389/fphar.2022.888222. eCollection 2022. Front Pharmacol. 2022. PMID: 35721207 Free PMC article. Review.

7

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.

Loría F, Petrosino S, Hernangómez M, Mestre L, Spagnolo A, Correa F, Di Marzo V, Docagne F, Guaza C. Loría F, et al. Neurobiol Dis. 2010 Jan;37(1):166-76. doi: 10.1016/j.nbd.2009.09.020. Epub 2009 Oct 6. Neurobiol Dis. 2010. PMID: 19815071

8

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

Mestre L, Docagne F, Correa F, Loría F, Hernangómez M, Borrell J, Guaza C. Mestre L, et al. Among authors: loria f. Mol Cell Neurosci. 2009 Feb;40(2):258-66. doi: 10.1016/j.mcn.2008.10.015. Epub 2008 Nov 19. Mol Cell Neurosci. 2009. PMID: 19059482

9

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

Correa F, Docagne F, Mestre L, Loría F, Hernangómez M, Borrell J, Guaza C. Correa F, et al. Among authors: loria f. Neuroimmunomodulation. 2007;14(3-4):182-7. doi: 10.1159/000110644. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073512 Review.

10

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.

Loría F, Petrosino S, Mestre L, Spagnolo A, Correa F, Hernangómez M, Guaza C, Di Marzo V, Docagne F. Loría F, et al. Eur J Neurosci. 2008 Aug;28(4):633-41. doi: 10.1111/j.1460-9568.2008.06377.x. Epub 2008 Jul 24. Eur J Neurosci. 2008. PMID: 18657182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page